Tóth, E., Orbán-Kálmándi, R., Bagoly, Z., Lóczi, L., Deli, T., Török, O., Deliné Molnár, S., Baráth, S., Singh, P., Hevessy, Z., Katona, É., Fagyas, M., Szabó, A., Molnár, S., Krasznai, Z.: Case report: Complex evaluation of coagulation, fibrinolysis and inflammatory cytokines in a SARS-CoV-2 infected pregnant woman with fetal loss.
Front. Immunol. 15 1-10, 2024.

Ghansah, H., Orbán-Kálmándi, R., Bekéné Debreceni, I., Katona, É., Rejtő, L., Váróczy, L., Lóczi, L., Laat, B., Huskens, D., Kappelmayer, J., Bagoly, Z.: Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma.
Thromb. Res. 234 12-20, 2024.

Somodi, L., Horváth, E., Bárdos, H., Baráth, B., Pethő, D., Katona, É., Balla, J., Mutch, N., Muszbek, L.: Cellular FXIII in Human Macrophage-Derived Foam Cells.
Int. J. Mol. Sci. 24 (5), 1-12, 2023.

Katona, É.: Functional Consequences of Antibodies against Noncatalytic B Subunit of Factor XIII.
Thromb. Haemost. 123 (9), 855, 2023.

Raut, S., Katona, É., Riches-Duit, A., Coxon, C., Muszbek, L., Schroeder, V., Rigsby, P.: An international collaborative study to assign value for Total Factor XIII-B Subunit Antigen to the WHO 1st International Standard for Factor XIII Plasma, (02/206): communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen.
J. Thromb. Haemost. 20 (2), 525-531, 2022.

Székely, E., Orbán-Kálmándi, R., Szegedi, I., Katona, É., Baráth, B., Czuriga-Kovács, K., Lóczi, L., Molnárné Vasas, N., Fekete, I., Fekete, K., Berényi, E., Oláh, L., Csiba, L., Bagoly, Z.: Low [alfa]2-Plasmin Inhibitor Antigen Levels on Admission Are Associated With More Severe Stroke and Unfavorable Outcomes in Acute Ischemic Stroke Patients Treated With Intravenous Thrombolysis.
Front. Cardiovasc. Med. 9 1-14, 2022.

Kissné Bogáti, R., Katona, É., Shemirani, A., Balogh, E., Bárdos, H., Jeney, V., Muszbek, L.: The Effect of Activated FXIII, a Transglutaminase, on Vascular Smooth Muscle Cells.
Int. J. Mol. Sci. 23 (10), 1-15, 2022.

Baráth, B., Kissné Bogáti, R., Miklós, T., Kállai, J., Mezei, Z., Bereczky, Z., Muszbek, L., Katona, É.: Effect of [alfa]2-plasmin inhibitor heterogeneity on the risk of venous thromboembolism.
Thromb. Res. 203 110-116, 2021.

Plamenova, I., Zolkova, J., Sokol, J., Kolkova, Z., Bereczky, Z., Katona, É., Muszbek, L., Kubisz, P., Staško, J.: Genetic Background of Inherited Factor XIII-A Subunit Deficiency: review of the Literature and Description of Two New Cases.
Semin. Thromb. Hemost. 47 (7), 885-889, 2021.

Bagoly, Z., Baráth, B., Orbán-Kálmándi, R., Szegedi, I., Kissné Bogáti, R., Sarkady, F., Csiba, L., Katona, É.: Incorporation of [alfa]2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients.
Biomolecules. 11 (3), 1-13, 2021.

Gindele, R., Pénzes-Daku, K., Balogh, G., Kállai, J., Kissné Bogáti, R., Bécsi, B., Erdődi, F., Katona, É., Bereczky, Z.: Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods.
Biomolecules. 11 (4), 1-18, 2021.

Potor, L., Hendrik, Z., Patsalos, A., Katona, É., Méhes, G., Póliska, S., Csősz, É., Kalló, G., Komáromi, I., Combi, Z., Posta, N., Sikura, K., Pethő, D., Oros, M., Vereb, G., Tóth, C., Gergely, P., Nagy, L., Balla, G., Balla, J.: Oxidation of hemoglobin drives a proatherogenic polarization of macrophages in human atherosclerosis.
Antioxid. Redox Signal. 35 (12), 917-950, 2021.

Bovet, J., Hurják, B., Maistre, E., Katona, É., Pénzes-Daku, K., Muszbek, L.: Autoimmune Factor XIII Deficiency With Unusual Laboratory and Clinical Phenotype.
J. Thromb. Haemost. 18 (6), 1330-1334, 2020.

Hurják, B., Kovács, Z., Döncző, B., Katona, É., Haramura, G., Erdélyi, F., Shemirani, A., Sadeghi, F., Muszbek, L., Guttman, A.: N-glycosylation of blood coagulation factor XIII subunit B and its functional consequence.
J. Thromb. Haemost. 18 (6), 1302-1309, 2020.

Ząbczyk, M., Natorska, J., Bagoly, Z., Sarkady, F., Baráth, B., Katona, É., Bryk, A., Zettl, K., Wisniewski, J., Undas, A.: Plasma fibrin clots of pulmonary embolism patients present increased amounts of factor XIII and alpha2-antiplasmin at 3 months' anticoagulation since the acute phase.
J. Physiol. Pharmacol. 71 (4), 519-524, 2020.

Bryk, A., Siudut, J., Broniatowska, E., Bagoly, Z., Baráth, B., Katona, É., Undas, A.: Sex-specific alteration to α2-antiplasmin incorporation in patients with type 2 diabetes.
Thromb. Res. 185 88-62, 2020.

Pénzes-Daku, K., Hurják, B., Katona, É., Becs, G., Balla, J., Muszbek, L.: Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment.
Int. J. Mol. Sci. 21 1-15, 2020.

Orosz, A., Csapó, A., Bagoly, Z., Székely, E., Tóth, E., Kovács, B., Bereczky, Z., Muszbek, L., Katona, É.: A new ELISA method for the measurement of total α2-plasmin inhibitor level in human body fluids.
J. Immunol. Methods. 471 27-33, 2019.

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z., Bereczky, Z.: ALPHA-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism in Patients with Venous Thromboembolism.
Proceedings. 2 (9), 102-103, 2018.

Muszbek, L., Katona, É., Pénzes-Daku, K.: Antibodies against factor XIII subunits.
In: Factor XIII Clinical and Laboratory Aspects - ECAT Foundation. Eds.: Helena Laboratories, ECAT Foundation, Voorschoten, 17-21, 2017.

Muszbek, L., Pénzes-Daku, K., Katona, É.: Auto-, and alloantibodies against factor XIII: laboratory diagnosis and clinical consequences.
J. Thromb. Haemost. 16 (5), 822-832, 2018.

Balogh, L., Katona, É., Mezei, Z., Kállai, J., Gindele, R., Édes, I., Muszbek, L., Papp, Z., Bereczky, Z.: Effect of factor XIII levels and polymorphisms on the risk of myocardial infarction in young patients.
Mol. Cell. Biochem. 448 (1-2), 199-209, 2018.

Miklós, T., Balla, G., Balogh, L., Boda, Z., Szabó, Z., Molnár, É., Gindele, R., Katona, É., Bereczky, Z.: Effects of Serpinc1, Proc, Pros1 and Epcr Polymorphisms on the Plasma Levels of Natural Anticoagulants in Healthy Individuals and on the Risk of Venous Thromboembolism and Myocardial Infarction.
Proceedings. 2 (9), 78, 2018.

Miklós, T., Balla, G., Balogh, L., Boda, Z., Szabó, Z., Molnár, É., Gindele, R., Katona, É., Bereczky, Z.: Effects of SERPINC1, PROC, PROS1 and EPCR Polymorphisms on the Risk of Venous Thromboembolism and Myocardial Infarction in Young Individuals.
Res Pract Thromb Haemost. 2 178, 2018.

Baráth, B., Bagoly, Z., Szegedi, I., Orbán-Kálmándi, R., Csiba, L., Katona, É.: Incorporation of Alpha-2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients Receiving Thrombolytic Therapy.
Proceedings. 2 (9), 101-102, 2018.

Székely, E., Czuriga-Kovács, K., Bereczky, Z., Katona, É., Mezei, Z., Nagy, A., Tóth, N., Berényi, E., Muszbek, L., Csiba, L., Bagoly, Z.: Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients.
Sci. Rep. 8 (1), 1-9, 2018.

Muszbek, L., Pénzes-Daku, K., Katona, É., Kun, M., Bonnefoy, A., Vezina, Z., Szuber, N., Molnárné Rázsó, K., Bereczky, Z., Kerényi, A., Bécsi, B., Erdődi, F., Rivard, G.: Novel approach to the laboratory diagnosis of antibodies against coagulation factors, with special reference to antifactor XIII antibodies: SE2.4.
Clin. Chem. Lab. Med. 56 (9), 128-129, 2018.

Gindele, R., Colombo, R., Szabó, Z., Speker, M., Mezei, Z., Balogh, L., Katona, É., Bagoly, Z., Fiatal, S., Bereczky, Z.: Prevalence of Antithrombin Budapest 3 Mutation among Different Patients Groups; Investigation of the Age and Origin of Mutation Common in Hungary.
Proceedings. 2 (9), 76-77, 2018.

Katona, É., Kissné Bogáti, R., Miklós, T., Gindele, R., Speker, M., Fedoriska, V., Orosz, A., Mezei, Z., Bereczky, Z.: The Effect of Alpha-2 Plasmin Inhibitor Activity and Antigen Levels and p.Arg6Trp Polymorphism on the Risk of Venous Thromboembolism.
Res Pract Thromb Haemost. 2 324-324, 2018.

Bagoly, Z., Baráth, B., Szegedi, I., Orbán-Kálmándi, R., Csiba, L., Katona, É.: The Effect of Factor XIII Levels on the Incorporation of [alfa]2-plasmin Inhibitor into Fibrin Clots: association with the Therapeutic Outcome of Acute Ischemic Stroke Patients.
Res. Pract. Thromb. Haemost. 2 198-198, 2018.

Katona, É., Muszbek, L.: The laboratory diagnosis of inherited FXIII deficiencies and the measurement of FXIII activity and antigen level.
In: Factor XIII Clinical and Laboratory Aspects - ECAT Foundation. Eds.: Helena Laboratories, ECAT Foundation, Voorschoten, 22-26, 2017.

Muszbek, L., Katona, É., Kerényi, A.: Assessment of Factor XIII.
In: Hemostasis and Thrombosis. Eds.: Emmanuel J. Favaloro, Giuseppe Lippi, Humana Press Inc., New York, 277-297, 2017. ISBN: 9781493971947

Mezei, Z., Katona, É., Kállai, J., Bereczky, Z., Somodi, L., Molnár, É., Kovács, B., Miklós, T., Ajzner, É., Muszbek, L.: Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism.
Thromb. Res. 158 93-97, 2017.

Menegatti, M., Palla, R., Boscarino, M., Bucciarelli, P., Muszbek, L., Katona, É., Makris, M., Peyvandi, F.: Minimal factor XIII activity level to prevent major spontaneous bleeds.
J. Thromb. Haemost. 15 1728-1736, 2017.

Kun, M., Szuber, N., Katona, É., Pénzes-Daku, K., Bonnefoy, A., Bécsi, B., Erdődi, F., Rivard, G., Muszbek, L.: Severe bleeding diatheses in an elderly patient with combined type autoantibody against factor XIII A subunit: novel approach to the diagnosis and classification of anti-factor XIII antibodies.
Haemophilia. 23 (4), 590-597, 2017.

Pénzes-Daku, K., Vezina, C., Bereczky, Z., Katona, É., Kun, M., Muszbek, L., Rivard, G.: Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy: characterization of the antibody.
Haemophilia. 22 (2), 268-275, 2016.

Muszbek, L., Katona, É.: Diagnosis and Management of Congenital and Acquired FXIII Deficiencies.
Semin. Thromb. Hemost. 42 429-439, 2016.

Pénzes-Daku, K., Molnárné Rázsó, K., Katona, É., Kerényi, A., Kun, M., Muszbek, L.: Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome: characterization of the antibody.
J. Thromb. Haemost. 14 (8), 1517-1520, 2016.

Mezei, Z., Katona, É., Kállai, J., Bereczky, Z., Molnár, É., Kovács, B., Ajzner, É., Bagoly, Z., Miklós, T., Muszbek, L.: Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism.
Thromb. Res. 148 101-106, 2016.

Homoródi, N., Kovács, E., Leé, S., Katona, É., Shemirani, A., Haramura, G., Balogh, L., Bereczky, Z., Szőke, G., Péterfy, H., Kiss, R., Édes, I., Muszbek, L.: The lack of aspirin resistance in patients with coronary artery disease.
J. Transl. Med. 14 (1), 74, 2016.

Mezei, Z., Bereczky, Z., Katona, É., Gindele, R., Balogh, E., Fiatal, S., Balogh, L., Czuriga, I., Ádány, R., Édes, I., Muszbek, L.: Factor XIII B Subunit Polymorphisms and the Risk of Coronary Artery Disease.
Int. J. Mol. Sci. 16 (1), 1143-1159, 2015.

Árokszállási, A., Kerényi, A., Katona, É., Bereczky, Z., Muszbek, L., Boda, Z., Schlammadinger, Á.: The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency - the first experience.
Haemophilia. 21 (1), e118-e121, 2015.

Mocanu, M., Ganea, C., Georgescu, L., Váradi, T., Shrestha, D., Baran, I., Katona, É., Nagy, P., Szöllősi, J.: Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.
J. Nat. Prod. 77 (2), 250-257, 2014.

Kovács, E., Katona, É., Bereczky, Z., Homoródi, N., Balogh, L., Tóth, E., Péterfy, H., Kiss, R., Édes, I., Muszbek, L.: Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods.
Thromb. Res. 133 (5), 811-816, 2014.

Katona, É., Muszbek, L., Devreese, K., Kovács, K., Bereczky, Z., Jonkers, M., Shemirani, A., Mondelaers, V., Ermens, A.: Factor XIII deficiency: complete phenotypic characterization of two cases with novel causative mutations.
Haemophilia. 20 (1), 114-120, 2014.

Katona, É., Pénzes-Daku, K., Csapó, A., Fazakas, F., Udvardy, M., Bagoly, Z., Orosz, Z., Muszbek, L.: Interaction of factor XIII subunits.
Blood. 123 (11), 1757-1763, 2014.

Kovács, E., Katona, É., Bereczky, Z., Homoródi, N., Balogh, L., Tóth, E., Péterfy, H., Kiss, R., Édes, I., Muszbek, L.: New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals.
Thromb. Res. 131 (4), 320-324, 2013.

Bagoly, Z., Székely, E., Kovács, K., Mezei, Z., Katona, É., Kappelmayer, J., Csiba, L., Muszbek, L.: The effect of factor XIII and other regulators of fibrinolysis on the outcome of thrombolysis in ischemic stroke patients.
J. Thromb. Haemost. 11 (s2), 405-406, 2013.

Zsóri, K., Csiki, Z., Katona, É., Bereczky, Z., Shemirani, A.: Vitamin B12 level in peripheral arterial disease.
J. Thromb. Thrombolysis. 36 (1), 77-83, 2013.

Simon, Á., Bagoly, Z., Hevessy, Z., Csáthy, L., Katona, É., Vereb, G., Ujfalusi, A., Szerafin, L., Muszbek, L., Kappelmayer, J.: Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia.
Cytom. Part B. Clin. Cytom. 82B (4), 209-216, 2012.

Bagoly, Z., Katona, É., Muszbek, L.: Factor XIII and inflammatory cells.
Thromb. Res. 129 (Suppl.2), S77-S81, 2012.

Balogh, E., Bereczky, Z., Katona, É., Kőszegi, Z., Édes, I., Muszbek, L., Czuriga, I.: Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.
Thromb. Res. 129 (2), 133-138, 2012.

Katona, É., Pénzes-Daku, K., Molnár, É., Muszbek, L.: Measurement of factor XIII activity in plasma.
Clin. Chem. Lab. Med. 50 (7), 1191-1202, 2012.

Muszbek, L., Bereczky, Z., Bagoly, Z., Komáromi, I., Katona, É.: Factor XIII: a Coagulation Factor With Multiple Plasmatic and Cellular Functions.
Physiol. Rev. 91 (3), 931-972, 2011.

Orosz, Z., Katona, É., Facskó, A., Módis, L., Muszbek, L., Berta, A.: Factor XIII subunits in human tears: their highly elevated levels following penetrating keratoplasty.
Clin. Chim. Acta. 412 (3-4), 271-276, 2011.

Orosz, Z., Katona, É., Facskó, A., Berta, A., Muszbek, L.: A highly sensitive chemiluminescence immunoassay for the measurement of coagulation factor XIII subunits and their complex in tears.
J. Immunol. Methods. 353 (1-2), 87-92, 2010.

Muszbek, L., Bereczky, Z., Bagoly, Z., Shemirani, A., Katona, É.: Factor XIII and Atherothrombotic Diseases.
Semin. Thromb. Hemost. 36 (1), 018-033, 2010.

Ajzner, É., Schlammadinger, Á., Kerényi, A., Bereczky, Z., Katona, É., Haramura, G., Boda, Z., Muszbek, L.: Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.
Blood. 113 (3), 723-725, 2009.

Kiss, F., Simon, Á., Csáthy, L., Hevessy, Z., Katona, É., Kiss, C., Kappelmayer, J.: A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII.
Cytometry A. 73A (3), 194-201, 2008.

Bereczky, Z., Balogh, E., Katona, É., Czuriga, I., Kárpáti, L., Shemirani, A., Édes, I., Muszbek, L.: Decreased factor XIII levels in factor XIII A subunit Leu34 homozygous patients with coronary artery disease.
Thromb. Res. 121 (4), 469-476, 2008.

Shemirani, A., Szomják, E., Csiki, Z., Katona, É., Bereczky, Z., Muszbek, L.: Elevated factor XIII level and the risk of peripheral artery disease.
Haematologica. 93 (9), 1430-1432, 2008.

Muszbek, L., Bagoly, Z., Bereczky, Z., Katona, É.: The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis.
Cardiovasc. Hematol. Agents. Med. Chem. 6 190-205, 2008.

Bereczky, Z., Balogh, E., Katona, É., Kárpáti, L., Czuriga, I., Édes, I., Muszbek, L.: Elevated factor XIII level and the risk of myocardial infarction in women.
Haematologica. 92 (2), 287-288, 2007.

Vokó, Z., Bereczky, Z., Katona, É., Ádány, R., Muszbek, L.: Factor XIII Val34Leu variant protects against coronary artery disease: a meta-analysis.
Thromb. Haemost. 97 (3), 458-463, 2007.

Bereczky, Z., Balogh, E., Katona, É., Pocsai, Z., Czuriga, I., Széles, G., Kárpáti, L., Ádány, R., Édes, I., Muszbek, L.: Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit A Val34Leu polymorphism and fibrinogen concentration in the high risk Hungarian population.
Thromb. Res. 120 (4), 567-573, 2007.

Kiss, F., Hevessy, Z., Veszprémi, A., Katona, É., Kiss, C., Vereb, G., Muszbek, L., Kappelmayer, J.: Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A.
Thromb. Haemost. 96 (2), 176-182, 2006.

Kappelmayer, J., Simon, Á., Katona, É., Szántó, A., Nagy, L., Kiss, A., Kiss, C., Muszbek, L.: Coagulation factor XIII-A. A flow cytometric intracellular marker in the classification of acute myeloid leukemias.
Thromb. Haemost. 94 (2), 454-459, 2005.

Katona, É., Nagy, B., Kappelmayer, J., Baktai, G., Kovács, L., Marialigeti, T., Dezső, B., Muszbek, L.: Factor XIII in bronchoalveolar lavage fluid from children with chronic bronchoalveolar inflammation.
J. Thromb. Haemost. 3 (7), 1407-1413, 2005.

Muszbek, L., Katona, É., Bereczky, Z., Balogh, E., Czuriga, I., Kárpáti, L., Édes, I.: Factor XIII levels and factor XIII A subunit VAL34LEU polymorphism in patients with coronary sclerosis and myocardial infarction.
Clin. Chim. Acta. 355 (Suppl), S94-S94, 2005.

Peyvandi, F., Tagliabue, L., Menegatti, M., Karimi, M., Komáromi, I., Katona, É., Muszbek, L., Mannucci, P.: Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency.
Hum. Mutat. 23 (1), 98-107, 2004.

Inbal, A., Muszbek, L., Lubetsky, A., Katona, É., Levi, I., Kárpáti, L., Nagler, A.: Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation.
Blood Coagul. Fibrinolysis. 15 (3), 249-253, 2004.

Muszbek, L., Bereczky, Z., Katona, É.: Blood coagulation factor XIII: involvement in fibrinolysis and thrombosis.
In: Thrombosis : fundamental and clinical aspects. Ed.: by J. Arnout [et al.], Leuven University Press, Leuven, Belgium, 197-224, 2003. ISBN: 9058673359

Bereczky, Z., Katona, É., Muszbek, L.: Fibrin stabilization (factor XIII), fibrin structure and thrombosis.
Pathophysiol. Haemost. Thromb. 33 (5-6), 430-437, 2003.

Katona, É., Ajzner, É., Tóth, K., Kárpáti, L., Muszbek, L.: Enzyme-linked immunosorbent assay for the determination of blood coagulation factor XIII A-subunit in plasma and in cell lysates.
J. Immunol. Methods. 258 (1-2), 127-135, 2001.

Kárpáti, L., Penke, B., Katona, É., Balogh, I., Vámosi, G., Muszbek, L.: A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma.
Clin. Chem. 46 (12), 1946-1955, 2000.

Katona, É., Haramura, G., Kárpáti, L., Fachet, J., Muszbek, L.: A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2).
Thromb. Haemost. 83 268-73, 2000.

Nagy, B., Katona, É., Varga, A., Baktai, G., Kovács, L., Marialigeti, T.: Fibronectin a légzőrendszer "remodelling"-jében krónikus tüdőbeteg gyermekekben.
Gyermekgyógyászat. 2 145-152, 2000.

Balogh, I., Szőke, G., Kárpáti, L., Wartiovaara, U., Katona, É., Komáromi, I., Haramura, G., Pfliegler, G., Mikkola, H., Muszbek, L.: Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.
Blood. 96 (7), 2479-2486, 2000.

Nógrády, N., Pócsi, I., Paffard, S., Katona, É., Miles, R., Balázs, A., Karaffa, E., Fachet, J., Price, R., Szentirmai, A.: Development of ELISA and enzyme-linked immunofiltration assay (ELIFA) methods for monitoring cyclodextrin glycosyltransferase (CGTase) production and bacterial growth in Bacillus macerans batch cultures.
J. Biotechnol. 60 (1-2), 15-22, 1998.

Wei, S., Katona, É., Fachet, J., Fülöp, T., Robert, L., Jacob, M.: Epitope specificity of monoclonal and polyclonal antibodies to human elastin.
Int. Arch. Allergy Immunol. 115 33-41, 1998.

Kappelmayer, J., Katona, É., Muszbek, L.: Flow Cytometric Identification of Platelet And Monocyte Factor XIII by Novel Monoclonal Antibodies.
Br. J. Haematol. 102 (1), 138-138, 1998.

Nógrády, N., Pócsi, I., Katona, É., Jeney, V., Boross, P., Tőzsér, J., Fachet, J., Szentirmai, A.: Soluble cell-bound and extracellular cyclodextrin glycosyltransferases of Bacillus macerans show identical enzymological characteristics and antigenicity.
J. Basic Microbiol. 36 (5), 335-340, 1996.

Tóth, G., Kerekes, A., Katona, É., Fachet, J.: Az egészséges újszülöttek és koraszülöttek plasmafibronectin-szintjének alakulása az első életnapokban és pathológiás állapotokban.
Gyermekgyógyászat. 6 567-570, 1995.

Udvardy, M., Hársfalvi, J., Pósán, E., Káplár, M., Katona, É., Rák, K.: A primer haemostasis adheziv tényezői és a máj fibrinogenesis kapcsolata alkoholos májcirrhosisban.
Orv. Hetil. 135 (10), 523-526, 1994.

Nagy, B., Katona, É., Erdei, J., Karmazsin, L., Fachet, J.: Fibronectin in bronchoalveolar lavage fluid and plasma of dogs with acute inflammation of the lungs.
Acta pathol. microbiol. immunol. Scand. 99 (4), 387-390, 1991.

Fachet, J., Ábel, G., Juszupova, S., Imre, S., Katona, É., Erdei, J., Szöllősi, J., Chihara, G.: Potentiation of non-specific host defence by polysaccharides like lentinan: possible mechanisms.
Int. J. Immunotherapy. 5 (4), 167-176, 1989.

Nagy, B., Katona, É., Erdei, J., Székely, E., Marialigeti, T., Karmazsin, L., Fachet, J.: Fibronectin in bronchoalveolar lavage fluid and plasma from children with chronic inflammation of lungs.
Acta Paediatr. Scand. 77 (5), 727-733, 1988.

Nagy, B., Katona, É., Erdei, J., Maródi, L., Székely, E., Marialigeti, T., Karmazsin, L., Fachet, J.: Fibronectin on the bronchoalveolar surface in children with recurrent obstructive bronchitis.
Acta Paediatr. Hung. 29 (3-4), 261-269, 1988.

Ladányi, É., Debreczeni, M., Katona, É., Pogány, Z., Erdei, J., Fachet, J.: Fibronektin szint meghatározás ELISA technikával monoklonális ellenanyag felhasználásával progresszív szisztémás szklerozisban és morpheaban..
Bőrgyógyász. Venerol. Szle. 63 193-196, 1987.